Recently, Shanghai UniXell Biotechnology Co., LTD. (UniXell), a leader in the field of pluripotent stem cell drug development, announced the completion of tens of millions of yuan angel round financing. This round of financing was led by Taifu Capital, with Kunlun Capital and Hillhouse Venture Capital co-investing.